Metalloproteinases and cervical maturation

Frontiers of Hormone Research

Volumn 27, Issue , 2001, Pages 269-279

  Giles, Warwick ^a,b   Agrez, Michael ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE;

FEMALE; HUMAN; LABOR; PHYSIOLOGY; PREGNANCY; PREMATURE LABOR; REVIEW; URINE; UTERINE CERVIX;

CERVIX UTERI; FEMALE; HUMANS; LABOR, OBSTETRIC; METALLOENDOPEPTIDASES; OBSTETRIC LABOR, PREMATURE; PREGNANCY;

EID: 0035222992     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061032     Document Type: Article

References (33)

1. Winkler M, Rath W: Changes in the cervical extracellular matrix during pregnancy and parturition. J Perinat Med 1999;27:45-60.
2. Winkler M, Ruck P, Horny HP, Wehrmann M, Kemp B, Kaiserling E, Rath W: Expression of cell adhesion molecules by endothelium in the lower uterine segment during parturition at term. Am J Obstet Gynecol 1998;178:557-561.
3. Winkler M, Fischer DC, Ruck P, Marx T, Kaiserling E, Oberpichler A, Tschesche H, Rath W: Parturition at term: Parallel increases in interleukin-8 and proteinase concentrations and neutrophil count in the lower uterine segment. Hum Reprod 1999;14:1096-1100.
4. Rath W, Winkler M, Kemp B: The importance of extracellular matrix in the induction of preterm delivery. J Perinat Med 1998;26:437-441.
5. Fortunato SJ, Menon R, Bryant C, Lombardi SJ: Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of the membranes. Am J Obstet Gynecol 2000;182:1468-1476.
6. Maymon E, Romero R, Pacora P, Gervasi M-T, Edwin ST, Gomez R, Seubert DE: Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 2000;182:1545-1553.
7. Morgan M, Kniss D, McDonnell S: Expression of metalloproteinases and their inhibitors in human trophoblast continuous cell lines. Exp Cell Res 1998;242:18-26.
8. Osmers RG, Adelmann-Grill BC, Rath W: Biochemical events in cervical ripening and dilatation during pregnancy and parturition. J Obstet Gynaecol 1995;21:185-194.
9. Vadillo-Ortega F, Gonzalez-Avilla G, Furth EE, Lei H, Muschel RJ, Stetler-Stevenson WG, Strauss JF III: 92-kD type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labour. Am J Pathol 1995;146:148-156.
10. Vadillo-Ortega F, Hernandez A, Gonzales-Avila G, Burmejo L, Iwata K, Strauss JF III: Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996;174:1371-1376.
11. Maymon E, Gomez R, Hassan S Edwin SS, Mazor M, Yoon BH, Romero R: A role for the 72 kD gelatinase and its inhibitor in human parturition. Am J Obstet Gynecol 1999;180:S11.
12. Fortunato SJ, Menon R, Lombardi SJ: Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane. Am J Obstet Gynecol 1997;177:731-741.
13. Qin X, Chua RH, Brynat-Greenwood GD: An autocrine/paracrine role of human decidual relaxin. II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinses-1 (TIMP-1). Biol Reprod 1997;56:812-820.
14. McLaren J, Taylor DJ, Bell SC: Increased levels of pro-metalloproteinase 9 in term fetal membranes overlying the cervix before labor: Implications for membrane remodelling and rupture. Am J Obstet Gynecol 2000;182:409-416.
15. Goldenberg RL, Andrews WW, Geurrant RL, Newman M, Mercer B, Iams J, Meis P, Moawad A, Das A, VanDorsten JP, Caritis SN, Thurnau G, Bottoms S, Miodovnik M, McNellis D, Roberts JM: The Preterm Prediction Study: Cervical lactoferrin concentration, other markers of lower genital tract infection, and preterm birth. Am J Obstet Gynecol 2000;182:631-635.
16. Fortunato SJ, Menon R, Lombardi SJ: Stromelysins in placental membranes and amniotic fluid with premature rupture of membranes. Obstet Gynecol 1999;94:435-440.
17. Athayde N, Edwin SS, Romero R, Gomez R, Maymon E, Pacora P, Menon R: A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol 1999;181:989-984.
18. Buhimschi IA, Kramer WB, Buhimshi CS, Thompson LP, Weiner CP: Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes. Am J Obstet Gynecol 2000;182:458-464.
19. Fortunato SJ, Menon R, Lombardi SJ: Il-10 inhibits Gelatinase-B (MMP-9) expression and release from human fetal membranes may reduce the risk of PROM. J Soc Gynecol Invest 2000;7:75A.
20. Goldenberg RL, Iams JD, Das A, Mercer BM, Meis PJ, Moawad AH, Miodovnik M, Van Dorsten PJ, Caritis SN, Thurnau GR, Dombowski MP, Roberts JM, McNellis D: The Preterm Prediction Study: Sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. Am J Obstet Gynecol 2000;182:636-643.
21. Rozenberg P, Goffinet F, Sage-Femme MH: Comparison of the Bishop score, ultrasonically measured cervical length, and fetal fibronectin assay in predicting time until delivery and type of delivery at term. Am J Obstet Gynecol 2000;182:108-113.
22. Lukes AS, Thorp JM Jr, Eucker B, Pahel-Short L: Predictors of positivity for fetal fibronectin in patients with symptoms of preterm labour. Am J Obstet Gynecol 1997;176:639-641.
23. Giles W, Knox M, Madsen G, Bisits A, Smith R: The effect of fetal fibronectin usage on admissions to a tertiary maternal fetal medicine unit and cost savings. Am J Obstet Gynecol 2000;182:439-442.
24. Agrez MV, Gu X, Giles W: Matrix metalloproteinase 9 activity in urine of patients at risk for preterm delivery. Am J Obstet Gynecol 1999;181:387-388.
25. Moses MA, Wiederschain D, Loughlin KR, Zurakowski D, Lamb CC, Freeman MR: Increased incidence of matrix metalloproteinase in urine of cancer patients. Cancer Res 1998;58:1395-1399.
26. Niu J, Gu X, Turton J, Meldrum C, Howard EW, Agrez MV: Integrin-mediated signalling of gelatinase B secretion in colon cancer cells. Biochem Biophys Res Commun 1998;249:287-291.
27. 6 integrin induces gelatinase B secretion in colon cancer cells Int J Cancer 1999;90:90-97.
28. Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, Nishimura SL, Aldape K, Landers DV, Carpenter W: Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial modeling. J Cell Sci 1995;108:2241-2251.
29. Lam H, Hamar B, Rosen T, Schatz F, Lockwood C: Thrombin effects on endometrial stromal cell levels of matrix metalloproteinase-1 and metalloproteinaes-3 may provide a link between bleeding and rupture of the fetal membranes. Am J Obstet Gynecol 1999;180:83.
30. Coleman MA, McCowan LM, Pattison NS, Mitchell M: Fetal fibronectin detection in preterm labour: Evaluation of a prototype bedside dipstick technique and cervical assessment. Am J Obstet Gynecol 1998;179:1553-1558.
31. Oliveira T, de Souza E, Mariani-Neto C, Camano L: Fetal fibronectin as a predictor of preterm delivery in twin pregnancies. Int J Gynaecol Obstet 1998;62:135-139.
32. Watson DL, Kim SJ, Humphrey MD: Study of cervicovaginal fibronectin status to guide treatment of threatened preterm labour. Aust NZ J Obstet Gynaecol 1998;38:185-187.
33. Lopez RL, Francis JA, Garite TJ, Dubyak JM: Fetal fibronectin detection as a predictor of preterm birth in actual clinical practice. Am J Obstet Gynecol 2000;182:1103-1106.